期刊文献+

多能性干细胞向红细胞定向诱导分化的研究进展

Research Advances on Directional Induction and Differentiation in vitro from Human Pluripotent Stem Cells into Erythrocytes——Review
下载PDF
导出
摘要 红细胞输注是临床上治疗急性失血和严重贫血的有效手段,然而目前血源紧张,因输血引起疾病传播等问题威胁着人类的健康。因此寻求安全、可靠、充足、有效的血液来源迫不及待。多能干细胞向红细胞体外分化的研究提供了一个潜在血液替代来源的选择。大量科研工作者进行了体外造血诱导的初步探索,包括定向分化体系及其效率的优化、红细胞的脱核成熟及功能鉴定、诱导型红细胞的安全性评价等。本文根据近年来这一领域的主要进展,着重对多能干细胞体外诱导分化为成熟型功能性红细胞的诱导方法以及调控机制进行综述,并对分化过程中存在的问题与挑战以及发展前景加以讨论。 Red blood cell transfusion is an effective method to treat acute hemorrhage and severe anemia.However,blood source from donors is very limited,and transfusion-transmitted diseases occured frequently,thus threatening human health.Therefore,the safe,abundant and functional blood source is needed.Generation of blood cells from human pluripotent stem cells (hPSC) will offer alternative approach.Lots of studies have been focused on erythroid cell differentiation in vitro,including how to enhance efficiency and improve their function.In this review,the research advances on differentiation methods and the regulatory mechanism are summarized.In addition,the progress in PSC differentiation into erythrocytes and the problems to be solved are discussed briefly.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2014年第1期213-218,共6页 Journal of Experimental Hematology
基金 2010年度高等学校博士学科点专项科研博导类基金(20100101110121)
关键词 胚胎干细胞 诱导性多能干细胞 红细胞 转录因子 embryonic stem cell induced pluripotent stem cell erythroid cell transcription factor
  • 相关文献

参考文献40

  • 1Allain JP,Stramer SL,Carneiro-Proietti AB. Transfusiontransmitted infectious diseases[J].Biologicals:journal of the International Association of Biological Standardization,2009,(2):71-77.
  • 2McKinney-Freeman S,Cahan P,Li H. The transcriptional landscape of hematopoietic stem cell ontogeny[J].Cell Stem Cell,2012,(5):701-714.
  • 3Pfaff N,Lachmann N,Kohlscheen S. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells[J].{H}STEM CELLS AND DEVELOPMENT,2012,(5):689-701.
  • 4Chang KH,Bonig H,Papayannopoulou T. Generation and characterization of erythroid cells from human embryonic stem cells and induced pluripotent stem cells:an overview[J].Stem cells international,2011.791604.
  • 5Lengerke C,Daley GQ. Autologous blood cell therapies from pluripotent stem cells[J].{H}Blood Reviews,2010,(1):27-37.
  • 6Tsiftsoglou AS,Vizirianakis IS,Strouboulis J. Erythropoiesis:Model systems,molecular regulators,and developmental programs[J].{H}IUBMB LIFE,2009,(8):800-830.
  • 7Kaufman DS. Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells[J].{H}Blood,2009,(17):3513-3523.
  • 8Ledran MH,Krassowska A,Armstrong L. Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches[J].Cell Stem Cell,2008,(1):85-98.
  • 9Zeuner A,Martelli F,Vaglio S. Concise review:stem cell-derived erythrocytes as upcoming players in blood transfusion[J].{H}STEM CELLS,2012,(8):1587-1596.
  • 10Olivier EN,Qiu C,Velho M. Large-scale production of embryonic red blood cells from human embryonic stem cells[J].{H}Experimental Hematology,2006,(12):1635-1642.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部